Lixte Biotechnology Files 8-K for Material Agreement
Ticker: LIXT · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1335105
| Field | Detail |
|---|---|
| Company | Lixte Biotechnology Holdings, INC. (LIXT) |
| Form Type | 8-K |
| Filed Date | Jul 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing-update
Related Tickers: LIXT
TL;DR
LIXT signed a material definitive agreement on July 3rd, filed today.
AI Summary
On July 8, 2025, Lixte Biotechnology Holdings, Inc. filed an 8-K report detailing a material definitive agreement entered into on July 3, 2025. The filing also includes other events and financial statements/exhibits. The company, incorporated in Delaware, operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates a significant new agreement for Lixte Biotechnology, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Registrant
- July 8, 2025 (date) — Report Date
- July 3, 2025 (date) — Earliest Event Reported
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the nature of the material definitive agreement entered into by Lixte Biotechnology Holdings, Inc. on July 3, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into on July 3, 2025.
What is Lixte Biotechnology Holdings, Inc.'s Standard Industrial Classification code?
Lixte Biotechnology Holdings, Inc. has a Standard Industrial Classification code of 2834, which corresponds to Pharmaceutical Preparations.
When was the 8-K report filed?
The 8-K report was filed on July 8, 2025.
In which state was Lixte Biotechnology Holdings, Inc. incorporated?
Lixte Biotechnology Holdings, Inc. was incorporated in Delaware.
What is the Commission File Number for Lixte Biotechnology Holdings, Inc.?
The Commission File Number for Lixte Biotechnology Holdings, Inc. is 001-39717.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).